Camille Sebaaly
Director of Finance/CFO chez SUNSHINE BIOPHARMA, INC.
Fortune : 10 468 $ au 31/03/2024
Profil
Camille Sebaaly is the founder of Advanomics Corp.
He is currently working as the Chief Financial Officer & Secretary at Sunshine Biopharma, Inc. since 2021.
Previously, he worked as the Chief Financial Officer & Secretary at Mountain West Business Solutions, Inc. in 2009 and at Sunshine Biopharma, Inc. in 2009.
Mr. Sebaaly completed his undergraduate degree from The State University of New York in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/03/2024 | 174 465 ( 0,18% ) | 10 468 $ | 31/03/2024 |
Postes actifs de Camille Sebaaly
| Sociétés | Poste | Début |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Director of Finance/CFO | 15/10/2009 |
Anciens postes connus de Camille Sebaaly
| Sociétés | Poste | Fin |
|---|---|---|
| Sunshine Biopharma, Inc. /Old/ | Director of Finance/CFO | 25/11/2009 |
| Mountain West Business Solutions, Inc. | Director of Finance/CFO | 25/11/2009 |
Advanomics Corp.
 Advanomics Corp. BiotechnologyHealth Technology Advanomics Corp. is a Canadian company that focuses on researching and developing treatments for cancer and other human diseases. The private company is based in Montréal, Canada. and has subsidiaries in Canada. The company was founded by Steve N. Slilaty and Camille Sebaaly. | Founder | - |
Formation de Camille Sebaaly
| The State University of New York | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Mountain West Business Solutions, Inc. | Commercial Services |
| Sunshine Biopharma, Inc. /Old/ | Commercial Services |
Advanomics Corp.
Advanomics Corp. BiotechnologyHealth Technology Advanomics Corp. is a Canadian company that focuses on researching and developing treatments for cancer and other human diseases. The private company is based in Montréal, Canada. and has subsidiaries in Canada. The company was founded by Steve N. Slilaty and Camille Sebaaly. | Health Technology |
